AutoCSA

AutoCSA detects small mutations in DNA sequencing traces to identify somatic variants in human cancers, including cases complicated by aneuploidy and admixture with normal tissue.

Key Features:

• High Sensitivity Detection: Detects small mutations ranging from 1 to 50 bases, including homozygous and heterozygous base substitutions and small insertions and deletions.
• Optimized for Cancer Genomics: Algorithm specifically tailored for high-throughput screening of cancer samples and for handling aneuploidy and admixture with normal tissue to improve heterozygous variant detection.
• High-throughput Processing: Designed to process large-scale sequencing screens efficiently to enable rapid variant detection in extensive datasets.
• Accuracy and Speed: Balances sensitivity with processing efficiency to provide accurate and timely identification of variants in sequencing traces.

Scientific Applications:

• Cancer Research: Identification of somatic variants in primary human cancers to support studies of tumor heterogeneity and the genetic basis of cancer.
• Genomic Studies: Detection of subtle mutations applicable to broader genomic investigations that require precise mutation calling.

Methodology:

AutoCSA employs a mutation-detection algorithm tailored to handle the complexities of cancer genomes, including aneuploidy and normal-tissue admixture, for efficient processing of sequencing traces.